Table 4

Partnership for Collaborative Action

Key collaborative partners
Research enterprise (public and private, researchers and funders)
Health care providers, including those providing home care
Community-based support
Patients and their family and friend caregivers
Policy makers and payers
An array of other essential partners (eg, government public health, foundations)
Domains of engagement for key partners
Formulating research questions and methods that address context
Reporting and interpreting research findings with greater attention to context
Disseminating findings and strengthening the evidence base in prevention, management, and care for persons with MCC
Translating findings into plain language in the patient’s context
Sustaining funding, advocacy, and other support for context in research and practice
Ongoing measurement and monitoring of progress and impact
Steps for building and sustaining collaborative partnership
Enumerate specific strategic partners
Establish common and compelling lexicons and stories
Engage partners
Foster innovation on context-informed research (eg, encourage funding announcements, FDA, IRBs to emphasize context-informed research)
Foster incorporation of context in practice (eg, cross-cutting clinical guidelines, performance measures, and patient-caregiver self-care management practice)
Continue reinforcing actions by partners
Measure and monitor effects and modulate actions
  • FDA = Federal Drug Administration; IRB = institutional review board; MCC = multiple chronic conditions.